Owlstone Medical, a company with offices in London and Cambridge, UK and Norwalk, CT, obtained the European CE Mark to introduce the pediatric version of its ReCIVA “disease breathalyzer”.
ReCIVA stands for Respiration Collector for In Vitro Analysis (ReCIVA), and as the name makes clear, it provides a standard way to capture breath samples that can be analyzed in the laboratory.
Both the adult and pediatric versions of the device are being used in a project at East Midlands Breathomics Pathology Node (EMBER) in the UK. The purpose is to develop a systematic approach for molecular pathology testing and to make breath analysis a standardized procedure.
The pediatric version of the device is intended for children age five years and older.
Professor Chris Brightling, EMBER and Leicester NIHR Respiratory Biomedical Research Unit Director, Professor in Respiratory Medicine at University of Leicester, Precision Medicine Institute, said in a statement, “Choosing the right treatment for the right patient is especially challenging in children as obtaining samples such as blood to measure disease activity can be difficult. Breath analysis offers an excellent opportunity to sample the airway by simply breathing into a mask. This presents a new approach to understand disease and make better treatment decisions”
Link to the product page of the adult version: ReCIVA…